Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 2025

Contributors Acknowledgements The authors would like to express their gratitude to the following people for their valuable contributions to this report, including key stakeholders from various sectors who were interviewed and others who reviewed this report. The paper does not necessarily reflect the views of these individuals and/or their organizations. Expert advice is purely consultative in nature and does not imply any association with the takeaways or conclusions presented in this paper. ADVANCE-ID Bayer AG Bayer Foundation China Center for Health Development Studies, Peking University ClavystBio Clinton Health Access Initiative (CHAI) Farm2Vet Food and Agriculture Organization of the United Nations (FAO) Forte BiotechGates Foundation Global Antibiotic R&D Partnership (GARDP) Ineos Oxford Institute for Antimicrobial Research Jhpiego Kyalio Luma Group Manipal Hospitals Novo Nordisk Foundation PhageLab reach52 TavLab, IIT-Delhi Temasek Foundation Temasek Life Sciences Laboratory The Trinity Challenge Wateroam Wellcome World Economic Forum Luis Alvarado Head, GAEA Christina Eng Project Engagement & Communications Specialist, GAEA Damien Gilbert Knowledge Specialist, GAEA Yvonne Leung Global Strategic Engagement Lead, GAEA Judith Moore Head, Healthcare Access & Outcomes Katie Young Initiative Lead, Healthcare System TransformationCentre for Impact Investing and Practices Levonne Goh Manager Sharon Koh Director Joanne Tan Intern Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 41